Charterhouse Capital Partners announced the first close of its CCP XII fund with €1bn ($1.1bn) secured, aiming for a total target of €1.5bn ($1.65bn). This follows the success of its previous fund, CCP XI, which closed at €1.4bn in 2023 and returned €2bn ($2.2bn) to investors through exits. The new fund focuses on pan-European mid-market businesses in services and healthcare, targeting companies valued between €150m and €1.5bn.

The firm has already deployed capital, including the December acquisition of medtech firm Winback. Investor demand for European mid-market strategies remains strong as limited IPO activity and market volatility drive allocations toward resilient private equity opportunities.

Charterhouse expanded its leadership team in 2024, appointing former NatWest Group CEO Alison Rose as senior partner to bolster expertise. With exits already underway, the fund reflects the firm’s track record of delivering returns while navigating complex market conditions.

This development underscores Charterhouse’s strategic positioning in Europe’s mid-market sector, leveraging sector-specific opportunities and experienced leadership to capitalize on long-term growth trends.